/PRNewswire/ Prapela, Inc., announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to explore the use of its.
President Biden signed into law the Modernization of Cosmetic Regulation Act which requires increased FDA oversight of cosmetics and the ingredients in them. The law creates requirements that may generate increased consumer litigation. These are the key provisions and timeline.
These measures follow the successful passage of H.R. 6833 in October, which included a five-year reauthorization of critical FDA user-fee programs that help ensure rare disease patients gain timely access to essential therapies and diagnostic tools.
Softgel Capsules Market is Expected to Reach US$ 1.7 Bn by the End of 2022, and Further Expand at a CAGR of 6% to Breach a Revenue of ~US$ 3.1 Bn by year 2
Softgel Capsules Market is Expected to Reach US$ 1.7 Bn by the End of 2022, and Further Expand at a CAGR of 6% to Breach a Revenue of ~US$ 3.1 Bn by year 2